Oct 13 (Reuters) – Cognition Therapeutics Inc: * COGNITION THERAPEUTICS ANNOUNCES ISSUANCE OF COMPOSITION OF MATTER PATENT, EXTENDING PROTECTION FOR ZERVIMESINE (CT1812) THROUGH 2045 * COGNITION
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 13 (Reuters) - Wells Fargo posted an increase in third-quarter profit on Tuesday, helped…
By Leo Marchandon Oct 13 (Reuters) - French cloud provider Scaleway said on Tuesday it…
INDIA FOREIGN MINISTRY: NO AMOUNT OF DENIAL BY CHINESE SIDE ON LADAKH CAN CHANGE THIS…
VIDEO SHOWS: HIGHLIGHTS OF AFC CHAMPIONS LEAGUE ELITE EAST REGION MATCH - NEWCASTLE JETS HOSTING…
New Delhi [India], October 13: Black Mango India Designs LLP, founded by F&B space designer…
By Svea Herbst-Bayliss, Saeed Azhar and Milana Vinn NEW YORK, Oct 13 (Reuters) - Bank…